Molecular targeted therapies for breast cancer treatment

@article{Schlotter2008MolecularTT,
  title={Molecular targeted therapies for breast cancer treatment},
  author={Claus M Schlotter and Ulf Vogt and Heike Allgayer and Burkhard Brandt},
  journal={Breast Cancer Research : BCR},
  year={2008},
  volume={10},
  pages={211 - 211}
}
Targeting the oestrogen receptor, HER2 (human epidermal growth factor receptor 2) and vascular endothelial growth factor has markedly improved breast cancer therapy. New targeted therapeutic approaches to induction of apoptosis or inhibition of anti-apoptosis, cell cycle progression, signal transduction and angiogenesis are described. The molecular pathways and their inhibitory or repair mechanisms are discussed in the preclinical and clinical settings. 

2 Figures & Tables

Connections & Topics

Mentioned Connections BETA
EstrogensContraindicated with diseaseMammary Neoplasms
Targeting the oestrogen receptor , HER2 ( human epidermal growth factor receptor 2 ) and vascular endothelial growth factor has markedly improved breast cancer therapy .
New targeted therapeutic approaches to induction of apoptosis or inhibition of anti - apoptosis , cell cycle progression , signal transduction and angiogenesis are described .
New targeted therapeutic approaches to induction of apoptosis or inhibition of anti - apoptosis , cell cycle progression , signal transduction and angiogenesis are described .
Targeting the oestrogen receptor , HER2 ( human epidermal growth factor receptor 2 ) and vascular endothelial growth factor has markedly improved breast cancer therapy .
All Topics